HJ Science (6132) Fundamentals 2026 — Revenue Analysis | SniperIQ
HJ Science (6132) is a CN-listed Healthcare company in Biotechnology with a market capitalization of HK
HJ Science's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 7.9x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
HJ Science runs a net profit margin of -1033.5%, a gross margin of 100.0%, and an operating margin of -959.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
HJ Science reported revenue of HK